Blue Sail Medical Co.,Ltd. manufactures and sells health protection gloves in China and internationally. The company offers disposable medical, latex, nitrile, PVC, TPE, and household gloves that are used for medical inspection and protection, food processing, electronics industry, etc. It is also involved in the research, development, production, and sales of cardiac stents and interventional cardiac surgery related equipment products. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is based in Zibo, China.
Оборотен капитал
2022
2021
2020
2019
2018
2017
Парични средства и инвестиции
2049.25
2839.86
3842.81
2243.20
1891.83
236.39
Приемници
0.00
0.00
0.00
0.00
0.00
0.00
Инвентарна книга
916.76
1124.54
768.77
416.01
422.41
247.34
Други
73.70
823.34
295.57
21.86
928.34
279.30
Общо текущи активи
4422.78
6341.27
7179.63
3444.82
3243.75
765.23
Acc Payable
266.82
464.49
785.30
431.87
533.20
229.32
Краткосрочен дълг
368.71
802.77
2174.79
1734.91
1271.62
61.26
Други текущи пасиви
1643.15
1916.89
694.26
490.77
446.12
86.78
Текущи пасиви
2278.68
3184.14
3654.35
2657.55
2306.54
391.23
Капиталова структура
Всички числа в милиони
Общо активи
311,14 щ.д.
Общо задължения
232336412,98 щ.д.
Дългосрочен дълг
0,00 щ.д.
Парични средства и екви
102300475,41 щ.д.
Goodwill
0,00 щ.д.
Неразпределена печалба
40921224,50 щ.д.
Обикновени акции
1007,10 щ.д.
Стойност на предприятието
-23,21 щ.д.
Дивиденти за маса
Години
Q1
Q2
Q3
Q4
Общо
2011
0.000
0.033
0.000
0.000
0.033
2012
0.000
0.025
0.000
0.000
0.025
2013
0.000
0.050
0.000
0.000
0.050
2014
0.000
0.031
0.000
0.000
0.031
2015
0.000
0.100
0.000
0.000
0.100
2016
0.000
0.200
0.000
0.000
0.200
2017
0.000
0.200
0.000
0.000
0.200
2018
0.200
0.000
0.000
0.000
0.200
2019
0.000
0.040
0.000
0.000
0.040
2020
0.000
0.100
0.000
0.000
0.100
2021
0.000
0.000
0.400
0.000
0.400
2023
0.000
0.400
0.000
0.000
0.400
Подобни запаси
Може да се интересувате и от
XRAY
DENTSPLY SIRONA Inc..
37.66 USD
NASDAQ
HAE
Haemonetics Corporation.
86.57 USD
NYSE
ATR
AptarGroup, Inc..
112.49 USD
NYSE
BLFS
BioLife Solutions, Inc..
23.35 USD
NASDAQ
MLSS
Milestone Scientific Inc..
1.02 USD
AMEX
ALICR.PA
I.CERAM SA.
7.65 EUR
EURONEXT
RMD
ResMed Inc..
218.69 USD
NYSE
MCDA
KMA Holding, Inc..
0.0001 USD
PNK
BDXB
Becton, Dickinson and Company.
48.16 USD
NYSE
AFX.DE
Carl Zeiss Meditec AG.
109 EUR
XETRA
Frequently Asked Question
Why is your stock tool better than competitors?
Numfin provides most features for free and gives you accurate and expert data about public companies. We also offer unique features like AI copilot that are not found on other platforms
Can I trust the data on your website and where do they come from?
Absolutely. We receive the data from our partners and other official sources, such as popular stock exchanges (NASDAQ, NYSE, and others), SEC.gov, and other official platforms. Our data provider, FinancialModeling, also provides information for portals like Moody's, Harvard, Chevron, and others. All this proves the accuracy and authority of the information.
Who creates the content on your website and is it approved by experts in finance and investing?
All financial data is received from our data provider and then verified by industry experts. Additionally, we use various AI tools like ChatGPT to present content in a user-friendly and well-structured manner.
What problem does your tool solve? Who is the target audience for your tool
Our main goal is to present accurate and expert information about public companies in a structured manner. We work with investors and financial professionals who have a long-term outlook. Our community consists of private investors, business owners, stock analysts, fund managers, and people who are interested in investing.
Why did you decide to create your tool?
While managing our own money, we searched for the best analytical tool to help us better analyze public companies. Most websites that provided analytics for professional investors were expensive, and the cheap tools were either limited in functionality or lacked valuable company data. Even worse, some of them presented incorrect numbers. As a result, we combined our experience in business, IT, and finance to create the most affordable and useful solution for investors and anyone interested in finance and stock analysis.
What is the difference between free and paid options? Should I buy Pro version from start or it's ok to have a free version?
Most features on our website are free so that many people can use it to analyze companies on the world's top stock exchanges. However, some features, such as our artificial intelligence chat, advanced analytics, filters, and storing of vast historical data, require additional servers from our end. Therefore, we rely on your support to keep this amazing project running. If you would like to experience the full potential of our service, we strongly recommend that you purchase the PRO version, which comes with a 30-day money-back guarantee
Who is your team and do they have enough experience?
You can read about our team here, or you can contact us at [email protected] for more information.
